BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Anika Announces the Forthcoming Appointment of Thomas M. Finnerty as Chief Human Resources Officer

  Anika announced the appointment of Thomas M. Finnerty as its Chief Human Resources Officer. Mr. Finnerty brings a 25-year track record of building global human resources teams, and specializes in talent acquisition and development, executive coaching,

  October 23, 2017

   · 

  3 min read
• Biotech Beach

  Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

  Arrowhead Pharmaceuticals announced that as an inducement to entering into employment with the Company, on October 17, 2017, eight new employees were awarded “inducement” grants of options under Rule 5635(c)(4) of the NASDAQ Marketplace Rules.

  October 23, 2017

   · 

  2 min read
• Biotech Beach

  Neurocrine Granted FDA Orphan Drug Designation for Valbenazine for the Treatment of Pediatric Patients With Tourette Syndrome

  Neurocrine today announced that valbenazine, a novel selective vesicular monoamine transporter 2 (VMAT2), has been granted Orphan Drug Designation by the FDA for the treatment of pediatric patients with Tourette syndrome.

  October 23, 2017

   · 

  6 min read
• 

  AstraZeneca Gets in on ADC Therapeutics’ Mega $200M Funding Round

  ADC Therapeutics announced it had raised $200M through an oversubscribed private placement.

  October 23, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Eli Lilly to Invest $72M in Indianapolis Diabetes Manufacturing

  In order to meet growing demand for insulin, pharma giant Eli Lilly said it will invest $72M to expand insulin manufacturing capabilities at one of its Indianapolis facilities.

  October 23, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Takeda’s Partner Merges With Crestovo to Form Finch Therapeutics Group

  Two privately-held biotechs have merged to tackle recurrent C. difficile infections.

  October 23, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Bay Area’s Global Blood Therapeutics Terminates Lung Disease Program

  The company is shuttering its GBT440 program to treat idiopathic pulmonary fibrosis (IPF).

  October 23, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  DBV Technologies Crashed as Allergy Drug Flunked Phase III Test

  DBV’s share price crumbled over the weekend after its Phase III peanut allergy trial failed to show a statistically significant response against placebo.

  October 23, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  FDA Calls Novartis’ Melanoma Combo Drug a Breakthrough

  The FDA based its decision on data from the COMBI-AD Phase III trial.

  October 23, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  BioMidwest

  These 3 Gene Therapy Biotechs Could Make Investors Rich

  Immuno-oncology and gene therapy has been a hot field for the last few years, and the approval of the first CAR-T therapies has only set the kindling ablaze.

  October 23, 2017

   · 

  3 min read

   · 

  Mark Terry